Inflammatory changes upon a single maximal exercise test in depressed patients and healthy controls

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 34, Issue 3, 2010, Pages 475-478

  Boettger, Silke ^a   Müller, Hans Josef ^b   Oswald, Klaus ^b   Puta, Christian ^b   Donath, Lars ^b   Gabriel, Holger H W ^b   Bär, Karl Jürgen ^a,c  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c ST JOSEF HOSPITAL   (Germany)

Author keywords

Cytokines; Exercise; Inflammation; Major depressive disorder; Stress

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; EXERCISE TEST; FEMALE; HUMAN; HUMORAL IMMUNITY; INFLAMMATION; LEUKOCYTE COUNT; MAJOR DEPRESSION; MALE; PROTEIN BLOOD LEVEL; RISK FACTOR;

ADULT; ANALYSIS OF VARIANCE; BLOOD CELL COUNT; BLOOD CELLS; DEPRESSIVE DISORDER, MAJOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXERCISE TEST; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MIDDLE AGED; PHYSICAL ENDURANCE; PSYCHIATRIC STATUS RATING SCALES; STATISTICS AS TOPIC;

EID: 77949653750     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.01.016     Document Type: Article

References (28)

1. Andreasson A., Arborelius L., Erlanson-Albertsson C., Lekander M. A putative role for cytokines in the impaired appetite in depression. Brain Behav Immun 2007, 21(2):147-152.
2. Anisman H. Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder. J Psychiatry Neurosci 2009, 34(1):4-20.
3. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961, 4:561-571.
4. Blumenthal J.A., Babyak M.A., Doraiswamy P.M., Watkins L., Hoffman B.M., Barbour K.A., et al. Exercise and pharmacotherapy in the treatment of major depressive disorder. Psychosom Med 2007, 69(7):587-596.
5. Boettger S., Wetzig F., Puta C., Donath L., Muller H.J., Gabriel H.H., et al. Physical fitness and heart rate recovery are decreased in major depressive disorder. Psychosom Med 2009, 71(5):519-523.
6. Boettger S., Puta C., Yeragani V.K., Donath L., Müller H.J., Gabriel H.H., et al. Heart rate variability, QT variability and electrodermal activity during exercise. Med Sci Sports Exerc 2010, 42(3):443-448.
7. Castanon N., Leonard B.E., Neveu P.J., Yirmiya R. Effects of antidepressants on cytokine production and actions. Brain Behav Immun 2002, 16(5):569-574.
8. Castellano V., Patel D.I., White L.J. Cytokine responses to acute and chronic exercise in multiple sclerosis. J Appl Physiol 2008, 104(6):1697-1702.
9. Cooper D.M., Radom-Aizik S., Schwindt C., Zaldivar F. Dangerous exercise: lessons learned from dysregulated inflammatory responses to physical activity. J Appl Physiol 2007, 103(2):700-709.
10. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008, 9(1):46-56.
11. Dill D.B., Costill D.L. Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration. J Appl Physiol 1974, 37(2):247-248.
12. Dunn A.L., Trivedi M.H., Kampert J.B., Clark C.G., Chambliss H.O. Exercise treatment for depression: efficacy and dose response. Am J Prev Med 2005, 28(1):1-8.
13. First M.B. Clinical utility: a prerequisite for the adoption of a dimensional approach in DSM. J Abnorm Psychol 2005, 114(4):560-564.
14. Gabriel H., Kindermann W. The acute immune response to exercise: what does it mean?. Int J Sports Med 1997, 18(Suppl 1):S28-S45.
15. Hamer M., Steptoe A. Association between physical fitness, parasympathetic control, and proinflammatory responses to mental stress. Psychosom Med 2007, 69(7):660-666.
16. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960, 23:56-62.
17. Huang T.L., Lee C.T. T-helper 1/T-helper 2 cytokine imbalance and clinical phenotypes of acute-phase major depression. Psychiatry Clin Neurosci 2007, 61(4):415-420.
18. Kim Y.K., Na K.S., Shin K.H., Jung H.Y., Choi S.H., Kim J.B. Cytokine imbalance in the pathophysiology of major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31(5):1044-1053.
19. Liukkonen T., Silvennoinen-Kassinen S., Jokelainen J., Rasanen P., Leinonen M., Meyer-Rochow V.B., et al. The association between C-reactive protein levels and depression: Results from the northern Finland 1966 birth cohort study. Biol Psychiatry 2006, 60(8):825-830.
20. Maes M., Lambrechts J., Bosmans E., Jacobs J., Suy E., Vandervorst C., et al. Evidence for a systemic immune activation during depression: results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining. Psychol Med 1992, 22(1):45-53.
21. Maes M., Meltzer H.Y., Bosmans E., Bergmans R., Vandoolaeghe E., Ranjan R., et al. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord 1995, 34(4):301-309.
22. McCarthy D.A., Dale M.M. The leucocytosis of exercise. A review and model. Sports Med 1988, 6(6):333-363.
23. Miller G.E., Stetler C.A., Carney R.M., Freedland K.E., Banks W.A. Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol 2002, 90(12):1279-1283.
24. Miller G.E., Rohleder N., Stetler C., Kirschbaum C. Clinical depression and regulation of the inflammatory response during acute stress. Psychosom Med 2005, 67(5):679-687.
25. Pace T.W., Hu F., Miller A.H. Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav Immun 2007, 21(1):9-19.
26. Pike J.L., Irwin M.R. Dissociation of inflammatory markers and natural killer cell activity in major depressive disorder. Brain Behav Immun 2006, 20(2):169-174.
27. Shephard R.J., Shek P.N. Autoimmune disorders, physical activity, and training, with particular reference to rheumatoid arthritis. Exerc Immunol Rev 1997, 3:53-67.
28. Sloan R.P., Shapiro P.A., Demeersman R.E., McKinley P.S., Tracey K.J., Slavov I., et al. Aerobic exercise attenuates inducible TNF production in humans. J Appl Physiol 2007, 103(3):1007-1011.